tiprankstipranks
Advertisement
Advertisement

PCINSIL Stock Latest News

Insilico Medicine Expands AI-Driven CNS Drug Partnership With China Medical System
Private CompaniesInsilico Medicine Expands AI-Driven CNS Drug Partnership With China Medical System
4h ago
INSIL
Insilico Medicine Posts Profit Surge as AI-Designed IPF Drug Enters Phase III
PremiumPrivate Companies
Insilico Medicine Posts Profit Surge as AI-Designed IPF Drug Enters Phase III
2d ago
INSIL
AI Benchmarking Targets Opioid Receptor Selectivity at Insilico Medicine
PremiumPrivate Companies
AI Benchmarking Targets Opioid Receptor Selectivity at Insilico Medicine
2d ago
INSIL
AI-Designed Drug Candidate Rentosertib Reaches Phase III With Abu Dhabi-Backed R&D Expansion
PremiumPrivate Companies
AI-Designed Drug Candidate Rentosertib Reaches Phase III With Abu Dhabi-Backed R&D Expansion
2d ago
INSIL
Insilico Medicine Expands Pharma AI Platform With New Generative Models and Automation Tools
PremiumPrivate Companies
Insilico Medicine Expands Pharma AI Platform With New Generative Models and Automation Tools
2d ago
INSIL
Insilico Medicine Takes Lead Role in Major Longevity Biotech Conference at Harvard
PremiumPrivate CompaniesInsilico Medicine Takes Lead Role in Major Longevity Biotech Conference at Harvard
2d ago
INSIL
Insilico Medicine Signals Strong H1 2026 Growth and Profitability
Premium
Private Companies
Insilico Medicine Signals Strong H1 2026 Growth and Profitability
3d ago
INSIL
Insilico Medicine Signals H1 2026 Profit Surge on AI Partnerships and Pipeline Momentum
Premium
Private Companies
Insilico Medicine Signals H1 2026 Profit Surge on AI Partnerships and Pipeline Momentum
4d ago
INSIL
Insilico Advances AI-Designed IPF Drug Rentosertib into Phase III, Marking Pivotal Late-Stage Milestone
PremiumPrivate Companies
Insilico Advances AI-Designed IPF Drug Rentosertib into Phase III, Marking Pivotal Late-Stage Milestone
6d ago
INSIL
Insilico Medicine Executive Spotlights AI Drug Discovery at Global Summit
PremiumPrivate Companies
Insilico Medicine Executive Spotlights AI Drug Discovery at Global Summit
6d ago
INSIL
Insilico Medicine Showcases ML Benchmarks for Synthetic Chemistry at ICML 2026
PremiumPrivate Companies
Insilico Medicine Showcases ML Benchmarks for Synthetic Chemistry at ICML 2026
6d ago
INSIL
Insilico Medicine – Weekly Recap
PremiumPrivate Companies
Insilico Medicine – Weekly Recap
9d ago
INSIL
Insilico Medicine Highlights $600 Million AI Drug Discovery Collaboration With Takeda
PremiumPrivate CompaniesInsilico Medicine Highlights $600 Million AI Drug Discovery Collaboration With Takeda
10d ago
INSIL
Insilico Medicine Highlights $600 Million Takeda Collaboration and AI Drug Discovery Strategy
Premium
Private Companies
Insilico Medicine Highlights $600 Million Takeda Collaboration and AI Drug Discovery Strategy
10d ago
INSIL
Insilico Medicine Secures Up to $600 Million Takeda Alliance to Scale AI Drug Discovery
Premium
Private Companies
Insilico Medicine Secures Up to $600 Million Takeda Alliance to Scale AI Drug Discovery
11d ago
INSIL
Insilico Medicine Pilots Quantum AI Chemistry Model Across R&D Ecosystem
PremiumPrivate Companies
Insilico Medicine Pilots Quantum AI Chemistry Model Across R&D Ecosystem
11d ago
INSIL
Insilico Medicine Highlights AI-Driven CNS Drug Discovery Collaboration With SK Biopharmaceuticals
PremiumPrivate Companies
Insilico Medicine Highlights AI-Driven CNS Drug Discovery Collaboration With SK Biopharmaceuticals
12d ago
INSIL
Insilico Medicine Highlights Pharma.ai Summer Update on AI-Driven Drug Discovery
PremiumPrivate Companies
Insilico Medicine Highlights Pharma.ai Summer Update on AI-Driven Drug Discovery
13d ago
INSIL
Insilico Medicine Emphasizes AI-Driven Drug Discovery, China Expansion and Long Cash Runway
PremiumPrivate Companies
Insilico Medicine Emphasizes AI-Driven Drug Discovery, China Expansion and Long Cash Runway
13d ago
INSIL
Insilico Medicine Secures $2.5 Billion CNS Deal as AI Drug Discovery Pipeline Expands
PremiumPrivate CompaniesInsilico Medicine Secures $2.5 Billion CNS Deal as AI Drug Discovery Pipeline Expands
16d ago
INSIL
Insilico Medicine Highlights $2.5 Billion CNS Collaboration and Expanding AI-Driven Pipeline
Premium
Private Companies
Insilico Medicine Highlights $2.5 Billion CNS Collaboration and Expanding AI-Driven Pipeline
16d ago
INSIL
Insilico Medicine Highlights AI Adoption Bottlenecks in Deep Tech
Premium
Private Companies
Insilico Medicine Highlights AI Adoption Bottlenecks in Deep Tech
16d ago
INSIL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >